Indaptus Therapeutics Inc. (INDP)
Indaptus Therapeutics Announces Reverse Stock Split
Indaptus Therapeutics Announces Reverse Stock Split
Portage Biotech Regains Full Compliance with Nasdaq Continued Listing Requirements
Gilead Sciences and Kymera Therapeutics Enter Into Exclusive Option and License Agreement to Develop Novel Oral Molecular Glue CDK2 Degraders